Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Page standards status: Informative |
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
a fhir:Library ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "179618"] ; #
fhir:meta [
fhir:versionId [ fhir:v "3" ] ;
fhir:lastUpdated [ fhir:v "2023-11-26T21:01:14.757Z"^^xsd:dateTime ] ;
( fhir:profile [
fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/systematic-review-included-studies"^^xsd:anyURI ;
fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/systematic-review-included-studies> ] )
] ; #
fhir:language [ fhir:v "en"] ; #
fhir:text [
fhir:status [ fhir:v "extensions" ] ;
fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n <table class=\"narrative-table\">\n <tbody>\n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\">Metadata</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">SystematicReviewIncludedStudies: ADT and Docetaxel vs. ADT alone for metastatic hormone-naive prostate cancer</td>\n\n\n</tr>\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Version</th>\n\n\n\n<td class=\"content-container\">1.0.0-ballot3</td>\n\n\n</tr>\n\n\n\n\n\n\n\n \n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Identifier</th>\n\n\n\n<td class=\"content-container\">179618</td>\n\n\n</tr>\n\n\n \n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Identifier</th>\n\n\n\n<td class=\"content-container\">urn:oid:2.16.840.1.113883.4.642.40.44.28.3</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Subject Type</th>\n\n\n\n<td class=\"content-container\"><a href=\"Group-179619.html\">SystematicReviewEligibilityCriteria: ADT and Docetaxel vs. ADT alone for metastatic hormone-naive prostate cancer</a></td>\n\n\n</tr>\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Use Context</th>\n\n\n\n<td class=\"content-container\">\n Evidence Communication\n\n = \n SystematicReviewIncludedStudies\n\n\n</td>\n\n\n</tr>\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Jurisdiction</th>\n\n\n\n<td class=\"content-container\">\n World\n\n\n</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Steward (Publisher)</th>\n\n\n\n<td class=\"content-container\">HL7 International / Clinical Decision Support</td>\n\n\n</tr>\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Steward Contact</th>\n\n\n\n<td class=\"content-container\">HL7 International / Clinical Decision Support</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Developer</th>\n\n\n\n<td class=\"content-container\">Brian S. Alper</td>\n\n\n</tr>\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Description</th>\n\n\n\n<td class=\"content-container\"><div><p>3 included studies</p>\n</div></td>\n\n\n</tr>\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Copyright</th>\n\n\n\n<td class=\"content-container\"><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>\n</div></td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Type</th>\n\n\n\n<td class=\"content-container\">\n Asset Collection\n\n\n</td>\n\n\n</tr>\n\n\n\n<tr>\n \n \n \n \n \n <td class=\"content-container\">\n \n \n \n \n \n \n \n </td>\n</tr>\n\n<tr>\n \n \n \n \n \n <td class=\"content-container\">\n \n \n \n \n \n \n \n </td>\n</tr>\n\n<tr>\n \n \n \n \n \n <td class=\"content-container\">\n \n \n \n \n \n \n \n </td>\n</tr>\n\n<tr>\n \n \n \n \n \n <td class=\"content-container\">\n \n \n \n \n \n \n \n </td>\n</tr>\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\"><a name=\"parameters\"> </a>Parameters</th>\n\n\n</tr>\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Parameter</th>\n\n\n\n<td class=\"content-container\">None</td>\n\n\n</tr>\n\n\n\n\n\n\n\n<tr>\n <th colspan=\"2\" scope=\"row\" class=\"row-header\">Generated using version 0.5.4 of the sample-content-ig Liquid templates</th>\n</tr>\n\n </tbody>\n </table>\n</div>"^^rdf:XMLLiteral ]
] ; #
fhir:extension ( [
fhir:url [
fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status"^^xsd:anyURI ;
fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status> ] ;
fhir:value [
a fhir:CodeableConcept ;
( fhir:coding [
fhir:system [
fhir:v "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type"^^xsd:anyURI ;
fhir:l <http://terminology.hl7.org/CodeSystem/cited-artifact-status-type> ] ;
fhir:code [ fhir:v "active" ] ;
fhir:display [ fhir:v "Active" ] ] ) ]
] ) ; #
fhir:url [
fhir:v "https://fevir.net/resources/Library/179618"^^xsd:anyURI ;
fhir:l <https://fevir.net/resources/Library/179618>
] ; #
fhir:identifier ( [
fhir:type [
( fhir:coding [
fhir:system [
fhir:v "http://terminology.hl7.org/CodeSystem/v2-0203"^^xsd:anyURI ;
fhir:l <http://terminology.hl7.org/CodeSystem/v2-0203> ] ;
fhir:code [ fhir:v "ACSN" ] ;
fhir:display [ fhir:v "Accession ID" ] ] ) ;
fhir:text [ fhir:v "FEvIR Object Identifier" ] ] ;
fhir:system [
fhir:v "https://fevir.net/FOI"^^xsd:anyURI ;
fhir:l <https://fevir.net/FOI> ] ;
fhir:value [ fhir:v "179618" ] ;
fhir:assigner [
fhir:display [ fhir:v "Computable Publishing LLC" ] ]
] [
fhir:system [
fhir:v "urn:ietf:rfc:3986"^^xsd:anyURI ;
fhir:l <urn:ietf:rfc:3986> ] ;
fhir:value [ fhir:v "urn:oid:2.16.840.1.113883.4.642.40.44.28.3" ]
] ) ; #
fhir:version [ fhir:v "1.0.0-ballot3"] ; #
fhir:title [ fhir:v "SystematicReviewIncludedStudies: ADT and Docetaxel vs. ADT alone for metastatic hormone-naive prostate cancer"] ; #
fhir:status [ fhir:v "active"] ; #
fhir:type [
( fhir:coding [
fhir:system [
fhir:v "http://terminology.hl7.org/CodeSystem/library-type"^^xsd:anyURI ;
fhir:l <http://terminology.hl7.org/CodeSystem/library-type> ] ;
fhir:code [ fhir:v "asset-collection" ] ;
fhir:display [ fhir:v "Asset Collection" ] ] )
] ; #
fhir:subject [
a fhir:Reference ;
fhir:l fhir:Group/179619 ;
fhir:reference [ fhir:v "Group/179619" ] ;
fhir:type [
fhir:v "Group"^^xsd:anyURI ;
fhir:l fhir:Group ] ;
fhir:display [ fhir:v "SystematicReviewEligibilityCriteria: ADT and Docetaxel vs. ADT alone for metastatic hormone-naive prostate cancer" ]
] ; #
fhir:date [ fhir:v "2023-11-26T18:15:27.442Z"^^xsd:dateTime] ; #
fhir:publisher [ fhir:v "HL7 International / Clinical Decision Support"] ; #
fhir:contact ( [
fhir:name [ fhir:v "HL7 International / Clinical Decision Support" ] ;
( fhir:telecom [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "http://www.hl7.org/Special/committees/dss" ] ] )
] ) ; #
fhir:description [ fhir:v "3 included studies"] ; #
fhir:useContext ( [
fhir:code [
fhir:system [
fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ;
fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ;
fhir:code [ fhir:v "evidence-communication" ] ;
fhir:display [ fhir:v "Evidence Communication" ] ] ;
fhir:value [
a fhir:CodeableConcept ;
( fhir:coding [
fhir:system [
fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ;
fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ;
fhir:code [ fhir:v "SystematicReviewIncludedStudies" ] ;
fhir:display [ fhir:v "SystematicReviewIncludedStudies" ] ] ) ]
] ) ; #
fhir:jurisdiction ( [
( fhir:coding [
fhir:system [
fhir:v "http://unstats.un.org/unsd/methods/m49/m49.htm"^^xsd:anyURI ;
fhir:l <http://unstats.un.org/unsd/methods/m49/m49.htm> ] ;
fhir:code [ fhir:v "001" ] ;
fhir:display [ fhir:v "World" ] ] )
] ) ; #
fhir:copyright [ fhir:v "https://creativecommons.org/licenses/by-nc-sa/4.0/"] ; #
fhir:author ( [
fhir:name [ fhir:v "Brian S. Alper" ]
] ) ; #
fhir:relatedArtifact ( [
fhir:type [ fhir:v "derived-from" ] ;
fhir:resourceReference [
fhir:l fhir:Citation/179613 ;
fhir:reference [ fhir:v "Citation/179613" ] ;
fhir:type [
fhir:v "Citation"^^xsd:anyURI ;
fhir:l fhir:Citation ] ;
fhir:display [ fhir:v "27308831 Efficacy and Safety of Combined Androgen Deprivation Therapy (ADT) and Docetaxel Compared with ADT Alone for Metastatic Hormone-Naive Prostate Cancer: A Systematic Review and Meta-Analysis." ] ]
] [
fhir:type [ fhir:v "contains" ] ;
fhir:resourceReference [
fhir:l fhir:Citation/179615 ;
fhir:reference [ fhir:v "Citation/179615" ] ;
fhir:type [
fhir:v "Citation"^^xsd:anyURI ;
fhir:l fhir:Citation ] ;
fhir:display [ fhir:v "23306100 Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial." ] ]
] [
fhir:type [ fhir:v "contains" ] ;
fhir:resourceReference [
fhir:l fhir:Citation/179617 ;
fhir:reference [ fhir:v "Citation/179617" ] ;
fhir:type [
fhir:v "Citation"^^xsd:anyURI ;
fhir:l fhir:Citation ] ;
fhir:display [ fhir:v "25301760 Survival with Newly Diagnosed Metastatic Prostate Cancer in the 'Docetaxel Era': Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)." ] ]
] [
fhir:type [ fhir:v "contains" ] ;
fhir:resourceReference [
fhir:l fhir:Citation/179616 ;
fhir:reference [ fhir:v "Citation/179616" ] ;
fhir:type [
fhir:v "Citation"^^xsd:anyURI ;
fhir:l fhir:Citation ] ;
fhir:display [ fhir:v "26244877 Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer." ] ]
] ) . #
IG © 2024+ HL7 International / Clinical Decision Support.
Package hl7.fhir.uv.ebm#1.0.0-ballot3 based on FHIR 6.0.0-ballot3.
Generated
2026-05-12
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change
